That this House congratulates the Imperial Cancer Research Fund, Cancer Research Campaign and the Ludwig Institute for backing the development of a vaccine against the human papilloma virus to protect women against cervical cancer that affects 4,000 women and causes 1,600 deaths every year; supports the clinical trials in Manchester and thanks the 30 volunteers and scientists involved in the trials; and hopes that a vaccine will be available to women within the next 10 years.

That this House congratulates the Imperial Cancer Research Fund, Cancer Research Campaign and the Ludwig Institute for backing the development of a vaccine against the human papilloma virus to protect women against cervical cancer that affects 4,000 women and causes 1,600 deaths every year; supports the clinical trials in Manchester...

That this House congratulates Professor Roland Wolf, head of the Imperial Cancer Research Fund's molecular pharmacology unit at Ninewells Hospital and Medical School in Dundee and his colleagues on their ground-breaking discovery in the battle against cancer, which complements recent achievements by Dundee-based Professors David Lane and Philip Cohen and their colleagues in this field; notes that these developments enhance the City of Dundee's fast-growing reputation as a centre of excellence in the field of health sciences and bio-technology; recognises that Dundee is indeed the 'City of Discovery'; and looks forward to further good news from Dundee through the BioDundee Initiative and innovative work by scientists based at the recently established and world-famous Wellcome Trust research building, bringing new advances in health care to the benefit of mankind.

That this House congratulates Professor Roland Wolf, head of the Imperial Cancer Research Fund's molecular pharmacology unit at Ninewells Hospital and Medical School in Dundee and his colleagues on their ground-breaking discovery in the battle against cancer, which complements recent achievements by Dundee-based Professors David Lane and Philip Cohen and...

That this House accepts that the threat to the Bristol Cancer Help Centre which only has funds until September and requires ??325,000 per annum to survive is directly attributable to the publication of the report on breast cancer patients commissioned and funded by the Imperial Cancer Research Fund and the Cancer Research Campaign, and in spite of warnings that the research was flawed; notes that the Charity Commission upheld complaints from the Bristol Survey Support Group that supervision of the study was inadequate and the information was badly handled, and also recommended guidelines on the responsibilities of charities funding medical research; deplores the fact that these research bodies should act in such a negligent manner; calls upon them to apologise to the women used as pawns in the research and to pay compensation both to the women for emotional distress, and to the Centre in line with the estimated ??1 million that adverse publicity has cost it in lost donations over five years; demands that the report be officially withdrawn; calls for the establishment of an equivalent body to the GMC to govern the field of misconduct in scientific research; and urges the Government to provide match funding in order to fully develop the BCHC's model into an invaluable subject of research and to foster its integration into maintstream health care.

That this House accepts that the threat to the Bristol Cancer Help Centre which only has funds until September and requires ??325,000 per annum to survive is directly attributable to the publication of the report on breast cancer patients commissioned and funded by the Imperial Cancer Research Fund and the...